{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:27:34Z","timestamp":1759541254004},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.mehy.2004.01.012","type":"journal-article","created":{"date-parts":[[2004,2,27]],"date-time":"2004-02-27T10:21:49Z","timestamp":1077877309000},"page":"646-652","source":"Crossref","is-referenced-by-count":16,"title":["Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?"],"prefix":"10.1016","volume":"62","author":[{"given":"Donald R","family":"Staines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.01.012_BIB1","unstructured":"Harrison\u2019s Principles of Internal Medicine. 14th ed. McGraw-Hill; 1998. p. 2483\u20135"},{"key":"10.1016\/j.mehy.2004.01.012_BIB2","series-title":"Principles and practice of infectious disease","author":"Mandell","year":"2000"},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000441-200308000-00001","article-title":"Abnormal impedence cardiography predicts symptom severity in chronic fatigue syndrome","volume":"326","author":"Peckerman","year":"2003","journal-title":"Am J. Med. Sci."},{"key":"10.1016\/j.mehy.2004.01.012_BIB4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2003.tb03145.x","article-title":"PACAP in immunity and inflammation","volume":"992","author":"Delgado","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2\u20133","key":"10.1016\/j.mehy.2004.01.012_BIB5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02787938","article-title":"Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies","volume":"47","author":"Paul","year":"1994","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.mehy.2004.01.012_BIB6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.1998.tb11180.x","article-title":"VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting peptide","volume":"865","author":"Brenneman","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1381612013398374","article-title":"Immunology of VIP: a review and therapeutical perspectives","volume":"7","author":"Gomarez","year":"2001","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1389203023380576","article-title":"PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signalling pathways","volume":"3","author":"Zhou","year":"2002","journal-title":"Curr. Protein Pept. Sci."},{"issue":"11","key":"10.1016\/j.mehy.2004.01.012_BIB9","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1074\/jbc.M107421200","article-title":"Activation of Trk neurotrophin receptor signalling by pituitary adenylate cyclase-activating polypeptides","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.166.2.1028","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, Nkappa B, NF-AT, and early growth factors 2\/3","volume":"166","author":"Delgado","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.mehy.2004.01.012_BIB11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2337\/diabetes.51.5.1453","article-title":"A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes","volume":"51","author":"Tsutsumi","year":"2002","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1076\/apab.109.4.372.4240","article-title":"VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibition and peripheral deletion of antigen-specific effectors","volume":"109","author":"Delgado","year":"2001","journal-title":"Arch. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/glia.10098","article-title":"Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia","volume":"39","author":"Delgado","year":"2002","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1076\/apab.109.4.377.4237","article-title":"Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo","volume":"109","author":"Delgado","year":"2001","journal-title":"Arch. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1076\/apab.109.4.365.4245","article-title":"TH2 lymphocytes secrete functional VIP upon antigen stimulation","volume":"109","author":"Vassiliou","year":"2001","journal-title":"Arch. Physiol. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.mehy.2004.01.012_BIB16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1566-0702(01)00379-4","article-title":"Neurokinin-1 receptors in the cerebrovascular vasoactive intestinal polypeptide-containing nerves of the rat","volume":"95","author":"Suzuki","year":"2002","journal-title":"Auton. Neurosci."},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1073\/pnas.012608999","article-title":"Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis","volume":"99","author":"Hamelink","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.mehy.2004.01.012_BIB18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/1381612033455116","article-title":"The neuropeptides VIP\/PACAP and T cells: inhibitors or activators","volume":"9","author":"Ganea","year":"2003","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1381612013398374","article-title":"Immunology of VIP: a review and therapeutical perspectives","volume":"7","author":"Gomariz","year":"2001","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000064942","article-title":"Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration","volume":"24","author":"Waschek","year":"2002","journal-title":"Dev. Neurosci."},{"issue":"12","key":"10.1016\/j.mehy.2004.01.012_BIB21","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/S0196-9781(02)00265-6","article-title":"Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice","volume":"23","author":"Bangale","year":"2002","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1357-2725(02)00177-2","article-title":"Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivo","volume":"35","author":"Gomariz","year":"2003","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1189\/jlb.0702372","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia","volume":"73","author":"Delgado","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.mehy.2004.01.012_BIB24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.1998.tb11180.x","article-title":"VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide","volume":"865","author":"Brenneman","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"1-2","key":"10.1016\/j.mehy.2004.01.012_BIB25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/JMN:13:1-2:199","article-title":"Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase activation to protect the developing mouse brain against excitotoxicity","volume":"13","author":"Gressens","year":"1999","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-328X(02)00646-0","article-title":"Morphine withdrawal is modified in pituitary adenylate cyclase-activating polypeptide type I-receptor-deficient mice","volume":"110","author":"Martin","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"9","key":"10.1016\/j.mehy.2004.01.012_BIB27","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1172\/JCI9387","article-title":"PAC1 receptor-deficient mice display impaired insulinotropic response to glucose reduced tolerance","volume":"105","author":"Jamen","year":"2000","journal-title":"Clin. Invest."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0024-3205(02)01639-9","article-title":"Pituitary adenylate cyclase activating polypeptide regulates the basal production of nitric oxide in PC12 cells","volume":"71","author":"Onoue","year":"2002","journal-title":"Life Sciences"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2004.01.012_BIB29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-0115(02)00065-4","article-title":"Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity","volume":"107","author":"Onoue","year":"2002","journal-title":"Regul. Pept."},{"issue":"11","key":"10.1016\/j.mehy.2004.01.012_BIB30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.01-0861hyp","article-title":"NMDA sensitisation and stimulation by peroxynitrite, nitric oxide and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity","volume":"16","author":"Pall","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.mehy.2004.01.012_BIB31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0306-4522(02)00506-7","article-title":"Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits","volume":"115","author":"Bao","year":"2002","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.mehy.2004.01.012_BIB32","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.167.6.3470","article-title":"The central nervous system inflammatory response to neurotropic virus infections is peroxynitrite dependent","volume":"167","author":"Hooper","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/152308601300185223","article-title":"Nitric oxide and blood-brain barrier integrity","volume":"3","author":"Thiel","year":"2001","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1054\/mehy.2001.1306","article-title":"Chronic fatigue syndrome: neurological findings may be related to blood-brain barrier permeability","volume":"57","author":"Bested","year":"2001","journal-title":"Med. Hypotheses"},{"issue":"18\u201319","key":"10.1016\/j.mehy.2004.01.012_BIB35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0024-3205(03)00076-6","article-title":"Nitric oxide (NO) synthase mRNA expression and NO production via muscarinic acetylcholine receptor-mediated pathways in the CEM, human leukemic T-cell line","volume":"72","author":"Kamimura","year":"2003","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB36","first-page":"32","article-title":"The blood level of nitric oxide metabolites in experimental autoimmune disease during immunosuppressive therapy","author":"Zviagina","year":"2003","journal-title":"Patol. Fitziol. Eksp. Ter."},{"issue":"3","key":"10.1016\/j.mehy.2004.01.012_BIB37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-1838(98)00051-4","article-title":"Inhibitory NANC neurotransmission in choledocho-duodenal junction of rabbits-possible role of PACAP","volume":"70","author":"Imoto","year":"1998","journal-title":"J. Auton. Nerv. Syst."},{"issue":"12","key":"10.1016\/j.mehy.2004.01.012_BIB38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system:pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.mehy.2004.01.012_BIB39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","article-title":"Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide","volume":"72","author":"Bassan","year":"1999","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.STR.0000014207.05597.D7","article-title":"NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death","volume":"33","author":"Leker","year":"2002","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.mehy.2004.01.012_BIB41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1189\/jlb.72.5.962","article-title":"Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway","volume":"72","author":"Bagley","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.mehy.2004.01.012_BIB42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jcb.10533","article-title":"Expression of genes for certain enzymes of pyrimidine and Purine salvage pathways in peripheral blood leukocytes collected from patients with Graves\u2019 or Hashimoto\u2019s disease","volume":"89","author":"Karbownik","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.mehy.2004.01.012_BIB43","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.4049\/jimmunol.171.8.3991","article-title":"Th1 cytokines regulate adenosine receptors and their downstream signalling elements in human microvascular endothelial cells","volume":"171","author":"Kho","year":"2003","journal-title":"J. Immunol."},{"issue":"October 9","key":"10.1016\/j.mehy.2004.01.012_BIB44","article-title":"Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells","author":"Schnurr","year":"2003","journal-title":"Blood"},{"issue":"6866","key":"10.1016\/j.mehy.2004.01.012_BIB45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in down regulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-2952(02)01548-4","article-title":"Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo","volume":"65","author":"Sitkovsky","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.mehy.2004.01.012_BIB47","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1189\/jlb.72.5.1027","article-title":"The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells","volume":"72","author":"Bshesh","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/art.10712","article-title":"Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68","volume":"48","author":"Montesinos","year":"2003","journal-title":"Arthritis. Rheum."},{"issue":"7","key":"10.1016\/j.mehy.2004.01.012_BIB49","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1046\/j.1460-9568.2000.00116.x","article-title":"VIP and PACAP potentiation of nicotinic Ach-evoked currents in rat parasympathetic neurons is mediated by G-protein activation","volume":"12","author":"Liu","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.mehy.2004.01.012_BIB50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0005-2736(00)00295-9","article-title":"Desensitisation, surface expression, and glycolisation of a functional, epitope-tagged type1 PACAP (PAC(1)) receptor","volume":"1509","author":"Shintani","year":"2000","journal-title":"Biochem. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.mehy.2004.01.012_BIB51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/JMN:15:3:137","article-title":"VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress","volume":"15","author":"Steingart","year":"2000","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-3806(96)00215-5","article-title":"Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity","volume":"99","author":"Gozes","year":"1997","journal-title":"Brain Res. Dev. Brain. Res."},{"issue":"1","key":"10.1016\/j.mehy.2004.01.012_BIB53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1189\/jlb.0702372","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia","volume":"73","author":"Delgado","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.mehy.2004.01.012_BIB54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/glia.10098","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia","volume":"39","author":"Delgado","year":"2002","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.mehy.2004.01.012_BIB55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jnr.10238","article-title":"Impairment of adenylyl cyclase and of spatial memory function after microsphere embolism in rats","volume":"68","author":"Nagakura","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.mehy.2004.01.012_BIB56","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1046\/j.1460-9568.2000.00116.x","article-title":"VIP and PACAP potentiation of nicotinic Ach-evoked currents in rat parasympathetic neurons is mediated by G-protein activation","volume":"12","author":"Liu","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mehy.2004.01.012_BIB57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02329922","article-title":"Autonomic dysfunction in Lambert\u2013Eaton myasthenic syndrome","volume":"11","author":"Waterman","year":"2001","journal-title":"Clin. Auton. Res."},{"issue":"13","key":"10.1016\/j.mehy.2004.01.012_BIB58","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1096\/fj.02-0248fje","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells","volume":"16","author":"Delgado","year":"2002","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.mehy.2004.01.012_BIB59","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/S0196-9781(02)00265-6","article-title":"Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice","volume":"23","author":"BangaleY","year":"2002","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.mehy.2004.01.012_BIB60","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappaB and IFN regulatory factor1 activation","volume":"162","author":"Delgado","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.mehy.2004.01.012_BIB61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/10799900252952235","article-title":"Structural and functional features of the 37-kDa 2-5A-dependent RnaseL in chronic fatigue syndrome","volume":"22","author":"Shetzline","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.mehy.2004.01.012_BIB62","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.20030530","article-title":"Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity","volume":"198","author":"Amedei","year":"2003","journal-title":"J. Exp. Med."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T01:14:01Z","timestamp":1682644441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0306987704000659"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.01.012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}